From Day 3, the expression levels of all indicators in the control group remained basically unchanged, while the mRNA and protein expressions of PLA2G6, LTB4R, and KL-6 in the BPD group increased gradually, and that of SOD decreased gradually. The gene discussed is PLA2G6; the disease is bronchopulmonary dysplasia.